FDA Inspection 1055690 — United Therapeutics Corporation
The FDA completed an inspection of United Therapeutics Corporation on May 3, 2018 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 3, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Durham, NC (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)